Final accounts and closure procedures

Introduction

Final accounts and closure procedures refer to the financial, administrative, legal, and regulatory activities undertaken when a biotechnology research project, clinical trial, field trial, or research institution completes its operations. These procedures ensure that financial resources are properly accounted for, research obligations are fulfilled, biological materials are safely disposed of or transferred, and regulatory authorities receive the necessary reports.

In biotechnology, closure is particularly important because research activities may involve genetically modified organisms, biological samples, laboratory animals, human participants, and potentially hazardous materials. Improper closure can create financial irregularities, environmental risks, and legal liabilities.

Meaning and objectives of final accounts

Final accounts provide a consolidated record of the financial position and expenditure of a research project at the time of completion. They demonstrate how grants, institutional funds, and external contributions have been utilised.

The main objectives include:

Establishing the total expenditure incurred during the project.

Identifying unspent funds and refundable balances.

Verifying expenditure against approved budgets.

Recording assets, equipment, and research materials.

Ensuring compliance with funding agreements.

Providing financial transparency and accountability.

In publicly funded biotechnology projects, final accounts are particularly important because research institutions must demonstrate that public money has been utilised for approved scientific purposes.

Legal framework governing final accounts and closure

1. Companies Act, 2013

Where biotechnology research is conducted through a company, the Companies Act, 2013, governs financial statements, accounting records, auditing, and corporate closure. Sections 128 and 129 deal with books of account and financial statements, while Section 134 concerns approval and reporting of financial statements.

2. General Financial Rules, 2017

Government-funded research institutions and grant recipients must comply with applicable financial management and utilisation requirements. Grant utilisation certificates, expenditure statements, and supporting records help establish whether funds were used for their approved purposes.

3. Environment (Protection) Act, 1986, and Rules, 1989

Biotechnology projects involving genetically engineered organisms must follow applicable biosafety conditions during closure. This may include the safe handling, containment, transfer, or disposal of regulated biological materials.

4. Prevention of Cruelty to Animals Act, 1960

Where animal experiments are conducted, closure must address the welfare and lawful management of animals used in research. Applicable institutional and CCSEA requirements must also be followed.

5. Clinical research regulations

Clinical trials must comply with the New Drugs and Clinical Trials Rules, 2019, where applicable. Trial completion involves regulatory reporting, documentation of participant safety, and fulfilment of applicable compensation and follow-up obligations.

Financial closure procedures

Financial closure involves preparing and verifying the final financial records of a research project.

The principal steps include:

1. Preparation of final expenditure statements: All expenditure relating to salaries, laboratory equipment, chemicals, field activities, travel, and other approved expenses must be recorded.

2. Reconciliation of accounts: Financial records should be compared with bank statements, invoices, purchase orders, and grant disbursement records.

3. Utilisation certificates: Institutions may be required to submit utilisation certificates and audited statements to the funding authority, depending on the grant conditions.

4. Settlement of liabilities: Outstanding payments to employees, suppliers, contractors, and service providers should be settled.

5. Treatment of unspent funds: Unutilised grant money must be handled according to the funding agreement and applicable government instructions. It may have to be refunded or adjusted against future approved expenditure.

Administrative and regulatory closure

Financial completion alone does not mean that a biotechnology project is legally closed. Administrative and regulatory responsibilities must also be completed.

Important activities include:

Submission of final scientific and technical reports.

Notification of project completion to relevant regulatory authorities.

Closure or transfer of research permissions where required.

Documentation of biological sample storage, transfer, or disposal.

Safe management of genetically engineered organisms and laboratory waste.

Completion of participant follow-up and compensation obligations, where applicable.

Preservation of research records for the required retention period.

For projects involving human participants, researchers must protect confidentiality and ensure that biological samples are managed according to consent conditions and applicable ethical requirements.

Important case laws

1. Institute of Chartered Accountants of India v. L.K. Ratna (1986)

The Supreme Court emphasised the importance of fairness and procedural safeguards in professional disciplinary proceedings. Its principles are relevant to financial accountability because institutions and professionals involved in research administration must be given fair procedures when allegations of financial or professional misconduct arise.

2. A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999)

The Supreme Court highlighted the importance of scientific expertise and informed regulatory decision-making in environmental matters. Its principles are relevant to the closure of biotechnology projects because environmental and biosafety responsibilities must be evaluated through competent scientific supervision.

3. Vellore Citizens' Welfare Forum v. Union of India (1996)

The Supreme Court recognised the precautionary principle and polluter-pays principle as important elements of Indian environmental law. These principles are relevant where biotechnology project closure involves contaminated materials, environmental damage, or remediation responsibilities.

4. Common Cause v. Union of India (2017)

The Supreme Court addressed accountability in the allocation and operation of natural resources, emphasising that public resources must be managed in accordance with legal requirements and public interest. Its broader principles support transparency and accountability in publicly funded research projects.

5. Animal Welfare Board of India v. A. Nagaraja (2014)

The Supreme Court recognised the importance of animal welfare and protection against unnecessary suffering. Its principles are relevant when closing research projects involving experimental animals, particularly concerning their humane and lawful management.

Challenges and recommendations

Final accounts and closure procedures may become complicated due to incomplete financial records, delayed utilisation certificates, unrecorded liabilities, improper biological waste disposal, and uncertainty regarding ownership of research assets.

To improve compliance, research institutions should maintain digital financial records, conduct periodic internal audits, establish clear closure responsibilities, and prepare a project-specific closure checklist. Independent verification should be undertaken wherever required by funding conditions or regulatory approvals.

Conclusion

Final accounts and closure procedures are essential for ensuring financial transparency, regulatory compliance, environmental safety, and institutional accountability in biotechnology research. Indian laws governing corporate accounting, public grants, biosafety, animal welfare, and clinical trials collectively establish important responsibilities for research organisations. Proper closure protects public funds, research participants, animals, and the environment while maintaining the credibility of scientific institutions.

Legal clarification: The cited judgments establish broader principles of financial accountability, environmental protection, procedural fairness, and animal welfare. They do not prescribe a single statutory closure procedure for every biotechnology project. Specific requirements depend on the project's funding agreement, regulatory approvals, and applicable laws.